Clinical Validation of a Urine- Based Assay with Genomic and Epigenomic Markers for Predicting Recurrence during Surveillance for Non-Muscle Bladder Cancer
|Effective start/end date||2/15/16 → 3/19/20|
- GENOMIC HEALTH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.